Shuoxi Xu

机构：Guangzhou University of Chinese Medicine, Guangdong Pharmaceutical University

发表论文 7 篇 · 总被引 268 次 · h-index 5

代表论文

• Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer (2024 · Molecular Cancer · 被引 110)
• Esculin inhibits hepatic stellate cell activation and CCl4-induced liver fibrosis by activating the Nrf2/GPX4 signaling pathway (2024 · Phytomedicine · 被引 87)
• Monotropein inhibits colitis associated cancer through VDR/JAK1/STAT1 regulation of macrophage polarization (2023 · International Immunopharmacology · 被引 33)
• Asperuloside inhibited epithelial-mesenchymal transition in colitis associated cancer via activation of vitamin D receptor (2022 · Phytomedicine · 被引 29)
• Combined Administration of Vitamin D3 and Geniposide Is Less Effective than Single Use of Vitamin D3 or Geniposide in the Treatment of Ulcerative Colitis (2021 · Frontiers in Pharmacology · 被引 7)
• Nystose mitigates mono sodium iodoacetate-induced knee osteoarthritis by inhibiting the NLRP3 Inflammasome (2025 · Phytomedicine · 被引 2)